Your browser doesn't support javascript.
loading
Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions.
Nagy, Magdolna; Perrella, Gina; Dalby, Amanda; Becerra, M Francisca; Garcia Quintanilla, Lourdes; Pike, Jeremy A; Morgan, Neil V; Gardiner, Elizabeth E; Heemskerk, Johan W M; Azócar, Lorena; Miquel, Juan Francisco; Mezzano, Diego; Watson, Steve P.
Afiliación
  • Nagy M; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
  • Perrella G; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
  • Dalby A; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Becerra MF; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Garcia Quintanilla L; Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom.
  • Pike JA; Laboratorio de Trombosis y Hemostasia, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Morgan NV; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Gardiner EE; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Heemskerk JWM; Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom.
  • Azócar L; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Miquel JF; ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia; and.
  • Mezzano D; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
  • Watson SP; Departmento de Gastroenterología, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Blood Adv ; 4(13): 2953-2961, 2020 07 14.
Article en En | MEDLINE | ID: mdl-32603422
ABSTRACT
The role of glycoprotein VI (GPVI) in platelets was investigated in 3 families bearing an insertion within the GP6 gene that introduces a premature stop codon prior to the transmembrane domain, leading to expression of a truncated protein in the cytoplasm devoid of the transmembrane region. Western blotting and flow cytometry of GP6hom (homozygous) platelets confirmed loss of the full protein. The level of the Fc receptor γ-chain, which associates with GPVI in the membrane, was partially reduced, but expression of other receptors and signaling proteins was not altered. Spreading of platelets on collagen and von Willebrand factor (which supports partial spreading) was abolished in GP6hom platelets, and spreading on uncoated glass was reduced. Anticoagulated whole blood flowed over immobilized collagen or a mixture of von Willebrand factor, laminin, and rhodocytin (noncollagen surface) generated stable platelet aggregates that express phosphatidylserine (PS). Both responses were blocked on the 2 surfaces in GP6hom individuals, but adhesion was not altered. Thrombin generation was partially reduced in GP6hom blood. The frequency of the GP6het (heterozygous) variant in a representative sample of the Chilean population (1212 donors) is 2.9%, indicating that there are ∼4000 GP6hom individuals in Chile. These results demonstrate that GPVI supports aggregation and PS exposure under flow on collagen and noncollagen surfaces, but not adhesion. The retention of adhesion may contribute to the mild bleeding diathesis of GP6hom patients and account for why so few of the estimated 4000 GP6hom individuals in Chile have been identified.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de la Coagulación Sanguínea / Glicoproteínas de Membrana Plaquetaria Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de la Coagulación Sanguínea / Glicoproteínas de Membrana Plaquetaria Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
...